Webinar: Next generation BioELN

Cellular therapeutics like CAR-T have revolutionised cancer treatment and hold immense promise in other areas of unmet medical need. Developing a new therapeutic cell line is no small task and requires the design and tracking of molecular tools, viral vectors, pluripotent stem cells and more. With projects spanning weeks and potentially multiple scientists, how can teams keep track of all inputs that go into developing new therapeutics? How can they trace back experimental steps to learn and build improvements?

DDW was pleased to host this free event, Accelerating cellular therapy discovery with the next generation BioELN, which was supported by PerkinElmer Informatics. Experts Dr. Christof Gänzler, Product Marketing Manager Biology, PerkinElmer Informatics, and Dr. Larry Mulcahy, Product Manager, Biologics PerkinElmer Informatics described how PerkinElmer Informatics’ BioELN accelerates scientific discovery of cellular therapeutics by capturing the entire workflow to accelerate cellular therapy discovery.

The event took place on 7 April at 4PM GMT, 11AM EST.

Download for free here.

What you will learn:

  • Learn about streamlined workflows to capture and share all data in a typical biologics discovery workflow
  • Learn how PerkinElmer Informatics BioELN can deliver functionality beyond a traditional ELN by combining electronic data capture with advanced data analytics and powerful search
  • Learn how researchers can document designs, register an array of molecular modalities, and assess sequence activity relationships

Who should register:

  • Directors, managers, researchers in biologics research




Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free